Marinella Govoni, PhD

MSD
Cento, Ferrara, Italy

Director Medical Affairs Immunology, MSD

Disclosure information not submitted.

Presentation(s):

• 0129: Effectiveness of Golimumab in the Treatment of Patients with Active Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis Who Failed Initial TNFα Therapy: A Pooled Analysis of European Prospective Observational Studies (the GO BEYOND Program)

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0129: Effectiveness of Golimumab in the Treatment of Patients with Active Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis Who Failed Initial TNFα Therapy: A Pooled Analysis of European Prospective Observational Studies (the GO BEYOND Program)

  Sunday, November 13, 2022
  2:00 PM – 2:05 PM Eastern Time